Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12121562 Antigenic Epstein Barr virus polypeptides

Patent 12121562 was granted and assigned to Sanofi on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kurt Swanson0

Gary J. Nabel0

Chih-Jen Wei0

Laura Nguyen0

Te-Hui Chou0

Date of Patent

October 22, 2024

0

Patent Application Number

180679400

Date Filed

December 19, 2022

0

Patent Citations

US Patent 9962436 Multimeric fusion protein vaccine and immunotherapeutic

0

US Patent 7951770 Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process

0

US Patent 8562996 RSV-specific binding molecules and means for producing them

0

US Patent 9703095 Light modulator for MEMS display

0

US Patent 10961283 Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens

0

Patent Primary Examiner

0

Patent abstract

This disclosure relates to antigenic EBV polypeptides and their use in eliciting antibodies against EBV. Also disclosed are antigenic polypeptides comprising an EBV polypeptide and a ferritin protein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12121562 Antigenic Epstein Barr virus polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool